BIO-RAD LABORATORIES, INC.
For the period ended Mar 31, 2026. Filed Apr 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed Apr 30, 2026
BIO-B$389.98+2.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income
Condensed Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended | ||
|---|---|---|
| March 31, | ||
| 2026 | 2025 | |
| Net income (loss) | $(527.1) | $64.0 |
| Other comprehensive income (loss), net of tax: | ||
| Foreign currency translation adjustments | (40.9) | 123.6 |
| Foreign other post-employment benefits adjustments | (0.5) | (0.2) |
| Net unrealized holding gains (losses) on available-for-sale investments | (6.0) | 5.0 |
| Net unrealized holding gains (losses) on cash flow hedge | 1.1 | — |
| Other comprehensive income (loss) | (46.3) | 128.4 |
| Comprehensive income (loss) | $(573.4) | $192.4 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.